Enveric Biosciences, Inc.
ENVB
$1.46
$0.042.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 191.12% | 14.31% | 108.72% | 20.76% | -18.64% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 13.76% | -- | -- | -- | -- |
| Prepaid Expenses | 7.02% | -15.52% | -36.35% | -31.51% | -45.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 96.88% | 1,275.00% | -79.32% | -95.00% | -99.68% |
| Total Current Assets | 165.87% | 11.18% | 80.53% | -3.98% | -40.08% |
|
|
|||||
| Total Current Assets | 165.87% | 11.18% | 80.53% | -3.98% | -40.08% |
| Net Property, Plant & Equipment | -66.03% | -55.14% | -47.94% | -46.56% | -40.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 152.05% | 8.22% | 65.32% | -8.94% | -41.36% |
|
|
|||||
| Total Accounts Payable | -34.41% | -58.11% | 11.37% | 18.64% | 126.35% |
| Total Accrued Expenses | -44.62% | -63.72% | -65.14% | -12.24% | 82.94% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -36.83% | -61.10% | -38.35% | 7.95% | 111.33% |
|
|
|||||
| Total Current Liabilities | -36.83% | -61.10% | -38.35% | 7.95% | 111.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -36.83% | -61.10% | -38.35% | 7.95% | 111.33% |
|
|
|||||
| Common Stock & APIC | 12.90% | 8.29% | 10.48% | 8.64% | 6.30% |
| Retained Earnings | -7.88% | -7.59% | -8.27% | -9.46% | -9.86% |
| Treasury Stock & Other | -3.70% | 1.82% | 2.44% | -8.58% | -1.24% |
| Total Common Equity | 269.94% | 29.18% | 162.27% | -12.53% | -59.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 269.94% | 29.18% | 162.27% | -12.53% | -59.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 269.94% | 29.18% | 162.27% | -12.53% | -59.59% |
|
|
|||||